Sponsor:
Andrew J. Armstrong, MD
Code:
NCT04709276
Conditions
Metastatic Prostate Neuroendocrine Carcinoma
Metastatic Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Ipilimumab
Carboplatin
Cabazitaxel
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations